KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Long-Term Debt Repayments (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Long-Term Debt Repayments for 17 consecutive years, with $200000.0 as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Repayments changed N/A to $200000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $500000.0 through Dec 2025, up 25.0% year-over-year, with the annual reading at $500000.0 for FY2025, 25.0% up from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $200000.0 at Bio-Rad Laboratories, roughly flat from $200000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $1.4 million in Q1 2021, with the low at $100000.0 in Q2 2024.
  • Average Long-Term Debt Repayments over 5 years is $273333.3, with a median of $122000.0 recorded in 2021.
  • The sharpest move saw Long-Term Debt Repayments tumbled 99.68% in 2021, then surged 100.0% in 2025.
  • Over 5 years, Long-Term Debt Repayments stood at $1.4 million in 2021, then tumbled by 90.33% to $133000.0 in 2022, then increased by 13.53% to $151000.0 in 2023, then plummeted by 33.77% to $100000.0 in 2024, then soared by 100.0% to $200000.0 in 2025.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $200000.0, $200000.0, and $100000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.